Results 271 to 280 of about 180,427 (290)

[Diffuse large B-cell lymphoma].

Medicina clinica, 2006
Parham, Khosravi Shahi, Gumersindo, Pérez Manga   +1 more
  +6 more sources

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

Lancet, The, 2013
David Cunningham, Eliza A Hawkes, Paul Mouncey   +2 more
exaly  

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

New England Journal of Medicine, 2018
Roland Schmitz, Dawei Huang, Calvin A Johnson   +2 more
exaly  

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Nature Reviews Clinical Oncology, 2020
Michael Weller, Martin J B Van Den Bent, Matthias Preusser   +2 more
exaly  

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

New England Journal of Medicine, 2019
Stephen J Schuster, Michael R Bishop, Constantine S Tam   +2 more
exaly  

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

Lancet, The, 2011
Christian Recher, Bertrand Coiffier, Corinne Haioun   +2 more
exaly  

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications

Cancer Cell, 2020
George W Wright, Dawei Huang, James D Phelan   +2 more
exaly  

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

New England Journal of Medicine, 2002
Bertrand Coiffier, Raoul Herbrecht, Gilles A Salles   +2 more
exaly  

Diffuse large B-cell lymphoma—treatment approaches in the molecular era

Nature Reviews Clinical Oncology, 2013
Mark J Roschewski, Louis M Staudt
exaly  

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

New England Journal of Medicine, 2002
Andreas Rosenwald, George W Wright, Wing C Chan   +2 more
exaly